A subsequent flow cytometry study confirmed that CCR6 is expressed on a relevant proportion of TPC-1 (bearing the RET/PTC rearrangement) and BCPAP (bearing the BRAF mutation) tumor cells, but not in normal human thyroid cells in basal conditions. The gene discussed is CCR6; the disease is neoplasm.